AAVS1 Knock-in

Hanqin Li, Dirk Hockemeyer

Published: 2022-09-06 DOI: 10.17504/protocols.io.b37kqrkw

Abstract

This protocol describes the standard procedure to knock-in constructs to the AAVS1 safe harbor locus in hPSCs.

General Notes:

  1. The AAVS1 knock-in construct, AAVS1-SA-neo-CAGGS-PE2-2A-GFP, can be found at AddGene (Catalog: 180014, RRID:Addgene_180014)

  2. Throughout this protocol, the term hPSC is used to collectively refer to both hiPSCs and hESCs. All described procedures have been tested and work equally well for hiPSCs and hESCs.

Steps

1.

One day before nucleofection, prepare two DR4 MEFs 6-well plates.

2.

Nucleofection of Cas9/sgRNA RNP (protospacer sequence, ACCCCACAGTGGGGCCACTA) and AAVS1 knock-in targeting vector is performed using the nucleofection of ribonucleoprotein (RNP) into human pluripotent stem cells (hPSCs) protocol as described in the collection "Nucleofection (Amaxa) and electroporation (Biorad) of hPSCs;" dx.doi.org/10.17504/protocols.io.b4qnqvve

After nucleofection, seed all cells onto two 6-well plates containing hPSCs medium + Rock Inhibitor.

2.1.

hPSCs Medium

AB
DMEM/F12385 ml
Fetal Bovine Serum (FBS)75 ml
Knockout Serum Replacement25 ml
L-Glutamine (100X)5 ml
Penicillin & Streptomycin (100X)5 ml
MEM Non-Essential Amino Acids (100X)5 ml
2-Mercaptoethanol (10,000X)50 µl
Heat Stable Recombinant Human FGF2 (25µg/ml)*80 µl

*While we prefer Heat Stable Recombinant Human FGF2, we also have used regular FGF2. Final volume: 500ml

L-Glutamine (100X)

AB
L-Glutamine, powder14.6 g
MilliQ H2O500 ml

2-Mercaptoethanol (10,000X)

AB
2-Mercaptoethanol0.78 ml
MilliQ H2O9.22 ml

Heat Stable Recombinant Human FGF2 (25µg/ml)

AB
Heat Stable Recombinant Human FGF2500 µg
0.1% BSA20 ml

Final volume: 20ml

Y-27632 (1,000X)

AB
Y-276325 mg
DMSO1.56 ml

hPSCs Medium + Rock Inhibitor

AB
hPSCs medium500 ml
Y-27632 (1,000X)500 µl

Final volume: 500ml

3.

From day 3, change medium daily for 10 days with hPSCs medium with 70 µg/ml G418. Most of the hPSCs will die during the G418 selection.

4.

When large hPSC colonies emerge, manually pick and re-plate them individually in 12-well ICR MEFs plates, as described in the collection "Standard operating procedure for the isolation of genetically engineered hPSCs clones in a high-throughput way;” dx.doi.org/10.17504/protocols.io.b4mmqu46

5.

When these expanded clones grow to 50%, passage 1/4 to a new well of a 6-well plate for further expanding.

For a detailed protocol on passaging hPSCs, refer to the collection "Thawing, Passaging and Freezing of hPSCs on MEFs;" dx.doi.org/10.17504/protocols.io.b4msqu6e

6.

Prepare crude cell lysate from the rest of the cells for genotyping as described in the collection “Genotyping by next generation sequencing;" dx.doi.org/10.17504/protocols.io.b4n3qvgn

7.

Freeze the expanded cells when they grow up.

For a detailed protocol on freezing hPSCs, refer to the collection "Thawing, Passaging and Freezing of hPSCs on MEFs;" dx.doi.org/10.17504/protocols.io.b4msqu6e

8.

Genotype crude cell lysate from step 6 using the primers flanking each homologous arm with GXL DNA polymerase. Use unedited cells as a negative control.

8.1.

Primer Sequences & Product Size

ABC
SP-AAVS1-HR-LCCCGCTTCAGTGACAACGTC1313bp
ASP-AAVS1-HR-LGAACTCTGCCCTCTAACGCT
SP-AAVS1-HR-RTGCATCGCATTGTCTGAGTAG1184bp
ASP-AAVS1-HR-RTACCCCGAAGAGTGAGTTTGC
9.

PCR with GXL DNA polymerase

9.1.

PCR with GXL DNA polymerase - Setup

AB
Ultrapure H2O11 µl
5x GXL buffer4 µl
2.5 mM dNTP1.6 µl
10 µM primer Forward0.5 µl
10 µM primer Reverse0.5 µl
PrimeStar GXL DNA polymerase0.4 µl
Crude cell lysis2 µl
10.

Touch-down PCR program

10.1.

Touch-down PCR program

AB
98°C3 min
98°C30 s
70°C (touch down, 1C/cycle)30 s
72°C1 min
Go to 212 cycles in total
98°C30 s
58°C1 min
72°C30 s
Go to 623 cycles in total
72°C7 min
4°C or 12°Cforever
11.

Run PCR products in agarose gels.

12.

Gel purify the bands of positively targeted clones and perform sanger sequencing to confirm.

13.

Thaw and expand the correctly targeted clones

14.

Test clones for mycoplasma, stain for pluripotent markers, and karyotype

推荐阅读

Nature Protocols
Protocols IO
Current Protocols
扫码咨询